Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Nitisinone Oral Suspension

Approval Number

国药准字HJ20233126

CompanySwedish Orphan Biovitrum International AB

Registration Date

February 14, 2023

Drug Information

Generic Name

尼替西农口服混悬液

Dosage Form

口服混悬剂

Strength

90ml:0.36g

Drug Type

化学药品

Registration Date

February 14, 2023

Expiry Date

February 13, 2028

Company Information

Applicant Company

Company NameSwedish Orphan Biovitrum International AB

Company Address

SE-112 76,Stockholm, Sweden

Manufacturing Company

Company NameApotek Produktion & Laboratorier AB

Company Address

Celsiusgatan 43 SE-212 14 Malmö, Sweden

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

尼替西农口服混悬液 - NMPA 批准文号 | MedPath